US Outdoor Performance Apparel Market

ID: MRFR/CG/12298-HCR
128 Pages
Tejas Chaudhary
Last Updated: April 06, 2026
US Outdoor Performance Apparel Market Size, Share, Industry Trend & Analysis Research Report By Product Type (Jackets & Vests, Pants & Trousers, Boots & Shoes, Base Layers, Compression Wear, Others), By Fabric Type (Woven, Knit), By Material (Natural, Synthetic), By End-User (Recreational, Professional), By Price Range (Economy/Mass, Premium), By Fabric Category (Running, Swimming & Water Sports, Cycling, Ski & Snow, Hunting & Fishing, Others), By Consumer (Men, Women, Children) andBy Distribution Channel (Store-based, Non-store-based)- Forecast to 2035
US Outdoor Performance Apparel Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.95%
2024 Market Size$ 4,500 Million
2025 Market Size$ 4,767.75 Million
2035 Market Size$ 8,500 Million
Key Players
Nike
Adidas
The North Face
Columbia Sportswear
Patagonia
Under Armour
Trends
  • Sustainability Focus
  • Technological Integration
  • Diverse Consumer Base
Opportunities
  • Health and Wellness Trends
  • Increased Outdoor Participation
  • E-commerce Growth and Accessibility
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Product Type (USD Million)
      1. 4.1.1 Jackets & Vests
      2. 4.1.2 Pants & Trousers
      3. 4.1.3 Boots & Shoes
      4. 4.1.4 Base Layers
      5. 4.1.5 Compression Wear
      6. 4.1.6 Others
    2. 4.2 Pharmaceutical, BY Fabric Type (USD Million)
      1. 4.2.1 Woven
      2. 4.2.2 Knit
    3. 4.3 Pharmaceutical, BY Material (USD Million)
      1. 4.3.1 Natural
      2. 4.3.2 Synthetic
    4. 4.4 Pharmaceutical, BY End-User (USD Million)
      1. 4.4.1 Recreational
      2. 4.4.2 Professional
    5. 4.5 Pharmaceutical, BY Price Range (USD Million)
      1. 4.5.1 Economic/Mass
      2. 4.5.2 Premium
    6. 4.6 Pharmaceutical, BY Fabric Category (USD Million)
      1. 4.6.1 Running
      2. 4.6.2 Swimming & Water Sports
      3. 4.6.3 Cycling
      4. 4.6.4 Ski & Snow
      5. 4.6.5 Hunting & Fishing
      6. 4.6.6 Others
    7. 4.7 Pharmaceutical, BY Consumer (USD Million)
      1. 4.7.1 Men
      2. 4.7.2 Women
      3. 4.7.3 Children
    8. 4.8 Pharmaceutical, BY Distribution Channel (USD Million)
      1. 4.8.1 Store-based
      2. 4.8.2 Non-store-based
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Nike (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Adidas (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 The North Face (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Columbia Sportswear (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Patagonia (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Under Armour (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Arc'teryx (CA)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Marmot (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Mountain Hardwear (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 US MARKET ANALYSIS BY FABRIC TYPE
    4. 6.4 US MARKET ANALYSIS BY MATERIAL
    5. 6.5 US MARKET ANALYSIS BY END-USER
    6. 6.6 US MARKET ANALYSIS BY PRICE RANGE
    7. 6.7 US MARKET ANALYSIS BY FABRIC CATEGORY
    8. 6.8 US MARKET ANALYSIS BY CONSUMER
    9. 6.9 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    10. 6.10 KEY BUYING CRITERIA OF PHARMACEUTICAL
    11. 6.11 RESEARCH PROCESS OF MRFR
    12. 6.12 DRO ANALYSIS OF PHARMACEUTICAL
    13. 6.13 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    14. 6.14 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    15. 6.15 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    16. 6.16 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY FABRIC TYPE, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY FABRIC TYPE, 2024 TO 2035 (USD Million)
    20. 6.20 PHARMACEUTICAL, BY MATERIAL, 2024 (% SHARE)
    21. 6.21 PHARMACEUTICAL, BY MATERIAL, 2024 TO 2035 (USD Million)
    22. 6.22 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
    23. 6.23 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
    24. 6.24 PHARMACEUTICAL, BY PRICE RANGE, 2024 (% SHARE)
    25. 6.25 PHARMACEUTICAL, BY PRICE RANGE, 2024 TO 2035 (USD Million)
    26. 6.26 PHARMACEUTICAL, BY FABRIC CATEGORY, 2024 (% SHARE)
    27. 6.27 PHARMACEUTICAL, BY FABRIC CATEGORY, 2024 TO 2035 (USD Million)
    28. 6.28 PHARMACEUTICAL, BY CONSUMER, 2024 (% SHARE)
    29. 6.29 PHARMACEUTICAL, BY CONSUMER, 2024 TO 2035 (USD Million)
    30. 6.30 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    31. 6.31 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    32. 6.32 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY FABRIC TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY MATERIAL, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
      5. 7.2.5 BY PRICE RANGE, 2025-2035 (USD Million)
      6. 7.2.6 BY FABRIC CATEGORY, 2025-2035 (USD Million)
      7. 7.2.7 BY CONSUMER, 2025-2035 (USD Million)
      8. 7.2.8 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Outdoor Performance Apparel Market Segmentation

US Outdoor Performance Apparel Market By Product Type (USD Million, 2025-2035)

  • Jackets & Vests
  • Pants & Trousers
  • Boots & Shoes
  • Base Layers
  • Compression Wear
  • Others

US Outdoor Performance Apparel Market By Fabric Type (USD Million, 2025-2035)

  • Woven
  • Knit

US Outdoor Performance Apparel Market By Material (USD Million, 2025-2035)

  • Natural
  • Synthetic

US Outdoor Performance Apparel Market By End-User (USD Million, 2025-2035)

  • Recreational
  • Professional

US Outdoor Performance Apparel Market By Price Range (USD Million, 2025-2035)

  • Economic/Mass
  • Premium

US Outdoor Performance Apparel Market By Fabric Category (USD Million, 2025-2035)

  • Running
  • Swimming & Water Sports
  • Cycling
  • Ski & Snow
  • Hunting & Fishing
  • Others

US Outdoor Performance Apparel Market By Consumer (USD Million, 2025-2035)

  • Men
  • Women
  • Children

US Outdoor Performance Apparel Market By Distribution Channel (USD Million, 2025-2035)

  • Store-based
  • Non-store-based

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.